Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

Author： Paludan Merete   Traberg Hansen Anders   Petersen Jørgen   Grau Cai   Høyer Morten  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.7, 2006-09, pp. : 818-822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 840-844

Spandidos Publications

Access to resources Recommend Favorite

Particle therapy: a suitable alternative to stereotactic body radiotherapy for stage I non-small-cell lung cancer?

By Shibamoto Yuta  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 353-356

Future Medicine

Access to resources Recommend Favorite

Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy

By              

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 1017-1022

Spandidos Publications

Access to resources Recommend Favorite

Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 281-287

Bentham Science Publishers

Access to resources Recommend Favorite

Stereotactic Body Radiation Therapy for Stage I Non-small-cell Lung Cancer: A Historical Overview of Clinical Studies

By Onishi Hiroshi   Araki Tsutomu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 345-350

Oxford University Press

Access to resources Recommend Favorite